These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20232387)

  • 1. Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice.
    Arlt VM; Zuo J; Trenz K; Roufosse CA; Lord GM; Nortier JL; Schmeiser HH; Hollstein M; Phillips DH
    Int J Cancer; 2011 Jan; 128(1):21-32. PubMed ID: 20232387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiles modulated by the human carcinogen aristolochic acid I in human cancer cells and their dependence on TP53.
    Simões ML; Hockley SL; Schwerdtle T; Gamboa da Costa G; Schmeiser HH; Phillips DH; Arlt VM
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):86-98. PubMed ID: 18639569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin Protects Mice from Aristolochic Acid I-Induced Kidney Injury by Induction of CYP1A through the Aromatic Hydrocarbon Receptor.
    Wang K; Feng C; Li C; Yao J; Xie X; Gong L; Luan Y; Xing G; Zhu X; Qi X; Ren J
    Int J Mol Sci; 2015 Jul; 16(7):16454-68. PubMed ID: 26204831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
    Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
    Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
    Stiborova M; Frei E; Arlt VM; Schmeiser HH
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles distinguish the carcinogenic effects of aristolochic acid in target (kidney) and non-target (liver) tissues in rats.
    Chen T; Guo L; Zhang L; Shi L; Fang H; Sun Y; Fuscoe JC; Mei N
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S20. PubMed ID: 17118142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of p53 on aristolochic acid I-induced nephrotoxicity and DNA damage in vivo and in vitro.
    Sborchia M; De Prez EG; Antoine MH; Bienfait L; Indra R; Valbuena G; Phillips DH; Nortier JL; Stiborová M; Keun HC; Arlt VM
    Arch Toxicol; 2019 Nov; 93(11):3345-3366. PubMed ID: 31602497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of p53 on Aristolochic Acid I-Induced Gene Expression In Vivo.
    Sborchia M; Keun HC; Phillips DH; Arlt VM
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues.
    Wang Y; Arlt VM; Roufosse CA; McKim KL; Myers MB; Phillips DH; Parsons BL
    Environ Mol Mutagen; 2012 Aug; 53(7):495-504. PubMed ID: 22729866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in Canines.
    Jin K; Su KK; Li T; Zhu XQ; Wang Q; Ge RS; Pan ZF; Wu BW; Ge LJ; Zhang YH; Wang YF; Shen GF; Zhu DY; Xiang CS; Li LJ; Lou YJ
    Cancer Prev Res (Phila); 2016 Apr; 9(4):324-34. PubMed ID: 26851235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
    Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
    Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
    Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
    Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
    Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I.
    Levova K; Moserova M; Nebert DW; Phillips DH; Frei E; Schmeiser HH; Arlt VM; Stiborova M
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):360-7. PubMed ID: 22982977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats.
    Stiborová M; Levová K; Bárta F; Šulc M; Frei E; Arlt VM; Schmeiser HH
    Mutagenesis; 2014 May; 29(3):189-200. PubMed ID: 24598128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microarray analysis reveals the inhibition of nuclear factor-kappa B signaling by aristolochic acid in normal human kidney (HK-2) cells.
    Chen YY; Chiang SY; Wu HC; Kao ST; Hsiang CY; Ho TY; Lin JG
    Acta Pharmacol Sin; 2010 Feb; 31(2):227-36. PubMed ID: 20139906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer.
    Stiborová M; Martínek V; Frei E; Arlt VM; Schmeiser HH
    Curr Drug Metab; 2013 Jul; 14(6):695-705. PubMed ID: 23701164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations as fingerprints for aristolochic acid: an environmental carcinogen in endemic (Balkan) nephropathy.
    Slade N; Moll UM; Brdar B; Zorić A; Jelaković B
    Mutat Res; 2009 Apr; 663(1-2):1-6. PubMed ID: 19428366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid.
    Hollstein M; Moriya M; Grollman AP; Olivier M
    Mutat Res; 2013; 753(1):41-49. PubMed ID: 23422071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
    Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
    Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.